Status:
UNKNOWN
Clinical Response to Biomarker Documentation of Child Secondhand Smoke Exposure
Lead Sponsor:
National Institutes of Health (NIH)
Conditions:
Biomarker Feedback
Smoking Cessation
Eligibility:
All Genders
12-36 years
Phase:
NA
Brief Summary
1. To do formative work with healthcare providers, clinic staff and parents to develop a protocol for a clinic system to routinely collect blood from children at risk of SHS exposure conduct laborator...
Detailed Description
ABSTRACT Smoking and secondhand smoke (SHS) are responsible for nearly a half-million preventable deaths in the United States every year. Parent(s) who stop smoking incur health benefits, model non-sm...
Eligibility Criteria
Inclusion
- 12M or 24M well-visit
- Scheduled to a lead test
- Current smoker
Exclusion
- Cannot speak English
- No phone
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01145729
Start Date
June 1 2010
End Date
December 1 2010
Last Update
June 17 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota Department of Medicine
Minneapolis, Minnesota, United States, 55414